Journal article
The impact of oral hypoglycemics and statins on outcomes in myelodysplastic syndromes
Abstract
Abstract
Observational studies suggest an anti-neoplastic effect associated with statins, metformin, and dipeptidyl peptidase-4 inhibitors (DPP4i), while sulfonylureas may have a neutral or detrimental effect. We linked the Ontario subset of a prospective Canadian myelodysplastic syndromes (MDS) registry with provincial administrative databases. We assessed the impact of statin/oral hypoglycemic medication exposure on overall survival (OS) …
Authors
Brailovski E; Li Q; Liu N; Leber B; Khalaf D; Sabloff M; Christou G; Yee K; Chodirker L; Parmentier A
Journal
Annals of Hematology, Vol. 101, No. 5, pp. 1023–1030
Publisher
Springer Nature
Publication Date
May 2022
DOI
10.1007/s00277-022-04802-1
ISSN
0939-5555